Zhou, S., Qin, X., Xing, W., Xu, Z., Wei, C., Ren, Y., & Gong, Z. Differences in treatment response and survival between HER2(2+)/FISH-positive and HER2(3+) breast cancer patients after dual-target neoadjuvant therapy: A matched case-control study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationZhou, Sicheng, Xuhui Qin, Wei Xing, Zhao Xu, Chunlv Wei, Yining Ren, and Zixing Gong. Differences in Treatment Response and Survival Between HER2(2+)/FISH-positive and HER2(3+) Breast Cancer Patients After Dual-target Neoadjuvant Therapy: A Matched Case-control Study. Frontiers Media S.A.
MLA (9th ed.) CitationZhou, Sicheng, et al. Differences in Treatment Response and Survival Between HER2(2+)/FISH-positive and HER2(3+) Breast Cancer Patients After Dual-target Neoadjuvant Therapy: A Matched Case-control Study. Frontiers Media S.A.